UBS Group’s Endologix Inc ELGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-20,000
| Closed | -$16K | – | 7783 |
|
|
2020
Q2 | $16K | Buy |
+20,000
| New | +$16K | ﹤0.01% | 5871 |
|
|
2019
Q1 | – | Sell |
-7,227
| Closed | -$52K | – | 7395 |
|
|
2018
Q4 | $52K | Buy |
7,227
+6,040
| +509% | +$43.5K | ﹤0.01% | 5169 |
|
|
2018
Q3 | $22K | Sell |
1,187
-476
| -29% | -$8.82K | ﹤0.01% | 5848 |
|
|
2018
Q2 | $94K | Buy |
1,663
+1,601
| +2,582% | +$90.5K | ﹤0.01% | 4612 |
|
|
2018
Q1 | $3K | Sell |
62
-354
| -85% | -$17.1K | ﹤0.01% | 6587 |
|
|
2017
Q4 | $23K | Buy |
416
+117
| +39% | +$6.47K | ﹤0.01% | 5497 |
|
|
2017
Q3 | $13K | Sell |
299
-41
| -12% | -$1.78K | ﹤0.01% | 5840 |
|
|
2017
Q2 | $16K | Sell |
340
-499
| -59% | -$23.5K | ﹤0.01% | 5534 |
|
|
2017
Q1 | $61K | Buy |
839
+829
| +8,290% | +$60.3K | ﹤0.01% | 4494 |
|
|
2016
Q4 | $1K | Sell |
10
-280
| -97% | -$28K | ﹤0.01% | 6678 |
|
|
2016
Q3 | $37K | Sell |
290
-815
| -74% | -$104K | ﹤0.01% | 4892 |
|
|
2016
Q2 | $137K | Buy |
1,105
+317
| +40% | +$39.3K | ﹤0.01% | 4005 |
|
|
2016
Q1 | $66K | Buy |
788
+251
| +47% | +$21K | ﹤0.01% | 4505 |
|
|
2015
Q4 | $54K | Sell |
537
-13
| -2% | -$1.31K | ﹤0.01% | 4695 |
|
|
2015
Q3 | $67K | Sell |
550
-289
| -34% | -$35.2K | ﹤0.01% | 4485 |
|
|
2015
Q2 | $128K | Buy |
839
+349
| +71% | +$53.2K | ﹤0.01% | 4147 |
|
|
2015
Q1 | $84K | Sell |
490
-278
| -36% | -$47.7K | ﹤0.01% | 4295 |
|
|
2014
Q4 | $117K | Buy |
+768
| New | +$117K | ﹤0.01% | 4121 |
|